Ashley F. Slagle

1.1k total citations
26 papers, 437 citations indexed

About

Ashley F. Slagle is a scholar working on Economics and Econometrics, Neurology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ashley F. Slagle has authored 26 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Economics and Econometrics, 6 papers in Neurology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ashley F. Slagle's work include Health Systems, Economic Evaluations, Quality of Life (11 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Meta-analysis and systematic reviews (3 papers). Ashley F. Slagle is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (11 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Meta-analysis and systematic reviews (3 papers). Ashley F. Slagle collaborates with scholars based in United States, United Kingdom and Belgium. Ashley F. Slagle's co-authors include Ari Gnanasakthy, Elektra J. Papadopoulos, Stephen Joel Coons, Ethan Basch, Paul G. Kluetz, Cindy Geoghegan, Laurie B. Burke, Stefan Cano, Elizabeth Molsen and Spiros Vamvakas and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Neurology.

In The Last Decade

Ashley F. Slagle

26 papers receiving 429 citations

Peers

Countries citing papers authored by Ashley F. Slagle

Since Specialization

Citations

This map shows the geographic impact of Ashley F. Slagle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley F. Slagle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley F. Slagle more than expected).

Fields of papers citing papers by Ashley F. Slagle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley F. Slagle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley F. Slagle. The network helps show where Ashley F. Slagle may publish in the future.

Co-authorship network of co-authors of Ashley F. Slagle

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley F. Slagle. A scholar is included among the top collaborators of Ashley F. Slagle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley F. Slagle. Ashley F. Slagle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The value of co-creating a clinical outcome assessment strategy for clinical trial research: process and lessons learnt 2023 ·Research Involvement and Engagement ·Thomas Morel, (unknown), Sophie Cleanthous, John Andrejack, (unknown), William S. Brooks, (unknown), (unknown), (unknown), Ashley F. Slagle	5
2	Plain language summary: what symptoms should be measured in clinical studies for early-stage Parkinson's? 2023 ·Future Neurology ·(unknown), Sophie Cleanthous, John Andrejack, (unknown), (unknown), William S. Brooks, Stefan Cano, (unknown), (unknown), (unknown), Ashley F. Slagle, (unknown), Thomas Morel, (unknown)	1
3	An Updated Review of Food and Drug Administration Warning and Untitled Letters for Clinical Outcome Assessment Claims Between 2013 and 2021 2023 ·Value in Health ·(unknown), Ashley F. Slagle, Tara Symonds, (unknown), Denise Globe	1
4	Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC): results from a cross-sectional study and a phase 3 clinical trial 2023 ·Journal of Patient-Reported Outcomes ·Eric K. H. Chan, Valerie Williams, Carla DeMuro, Sheri Fehnel, Ashley F. Slagle, Jeffrey J. Stoddard, Jerald Sadoff, (unknown), Sandy Lewis, (unknown), (unknown), Yan Liu, Eva G. Katz, Pauline McNulty, Ilse Van Dromme, Kelly McQuarrie	2
5	Recommendations on the Selection, Development, and Modification of Performance Outcome Assessments: A Good Practices Report of an ISPOR Task Force 2023 ·Value in Health ·Chris J. Edgar, Elizabeth Nicole Bush, Heather Adams, Rachel Ballinger, Bill Byrom, Michelle Campbell, Sonya Eremenco, Fiona McDougall, Elektra J. Papadopoulos, Ashley F. Slagle, Stephen Joel Coons	6
6	Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson’s 2023 ·Journal of Patient-Reported Outcomes ·Thomas Morel, Sophie Cleanthous, John Andrejack, Roger A. Barker, Milton Biagioni, (unknown), Bastiaan R. Bloem, Babak Boroojerdi, William S. Brooks, Paul Burns, Stefan Cano, (unknown), (unknown), (unknown), Ashley F. Slagle, (unknown), (unknown)	7
7	Psychometric Validation and Meaningful Change Thresholds of the New Nasal Polyposis Symptom Diary 2023 ·Annals of Otology Rhinology & Laryngology ·Vivian H. Shih, Ashley F. Slagle, Cristina Ivanescu, (unknown), Oren Meyers, James L. Kreindler, Ubaldo J. Martin, Viktoría Werkström	1
8	Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures 2022 ·ERJ Open Research ·Marlies Wijsenbeek, María Molina‐Molina, Olivier Chassany, John P. Fox, Liam Galvin, Klaus Geißler, Katherine M. Hammitt, Michael Kreuter, Teng Moua, Emily C. O’Brien, Ashley F. Slagle, (unknown), Matthew Reaney, Michael Baldwin, (unknown), Klaus Röhr, Jeff Swigris, Κατερίνα Αντωνίου	10
9	Development of a novel patient-reported outcome measure to assess signs and symptoms of COVID-19 2022 ·Journal of Patient-Reported Outcomes ·Carla DeMuro, Sheri Fehnel, Jeffrey J. Stoddard, Jerald Sadoff, Sandy Lewis, Pauline McNulty, Eric K. H. Chan, Emily Evans, Carol Jamieson, Ashley F. Slagle, Allen W. Mangel, Kelly McQuarrie	4
10	Patient Experience in Early-Stage Parkinson’s Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome Assessment 2022 ·Neurology and Therapy ·Thomas Morel, Sophie Cleanthous, John Andrejack, Roger A. Barker, (unknown), William S. Brooks, Paul Burns, Stefan Cano, (unknown), (unknown), (unknown), Ashley F. Slagle, (unknown), Babak Boroojerdi, (unknown), (unknown)	16
11	Development and content validation of a symptom assessment for eosinophilic gastritis and eosinophilic gastroenteritis in adults and adolescents 2021 ·Orphanet Journal of Rare Diseases ·(unknown), Sean O’Quinn, Julie Bailey, Oren Meyers, Ashley F. Slagle, Evan S. Dellon, Catherine Datto	2
12	Mo1184 AN EPISODE-BASED PATIENT-REPORTED OUTCOME MEASURE OF DYSPHAGIA EXPERIENCE IS FEASIBLE AND NOT BURDENSOME FOR PATIENTS WITH EOSINOPHILIC ESOPHAGITIS 2020 ·Gastroenterology ·Evan S. Dellon, (unknown), Jeffrey M. Rohay, (unknown), Ashley F. Slagle, Gina Eagle, James Nezamis, Peter Richardson, Jean Paty	1
13	Measurement Equivalence of Patient-Reported Outcome Measures Migrated to Electronic Formats: A Review of Evidence and Recommendations for Clinical Trials and Bring Your Own Device 2018 ·Therapeutic Innovation & Regulatory Science ·Bill Byrom, Chad Gwaltney, Ashley F. Slagle, Ari Gnanasakthy, Willie Muehlhausen	22
14	PRM9 - A LONGITUDINAL, ITEM-LEVEL ANALYSIS METHODOLOGY TO SUPPORT THE INTERPRETABILITY OF MULTI-ITEM PATIENT-REPORTED OUTCOMES 2018 ·Value in Health ·Stacie Hudgens, Lysbeth Floden, Tara Symonds, Ashley F. Slagle	1
15	Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force 2017 ·Value in Health ·John H. Powers, Donald L. Patrick, Marc K. Walton, Patrick Marquis, Stefan Cano, Jeremy Hobart, Maria Isaac, Spiros Vamvakas, Ashley F. Slagle, Elizabeth Molsen, Laurie B. Burke	106
16	Fit for purpose and modern validity theory in clinical outcomes assessment 2017 ·Quality of Life Research ·Michael C. Edwards, Ashley F. Slagle, Jonathan D. Rubright, R. Wirth	20
17	Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic Review 2015 ·Journal of Pain ·Shannon M. Smith, Florence Paillard, Andrew McKeown, Laurie B. Burke, Robert R. Edwards, Nathaniel P. Katz, Elektra J. Papadopoulos, Bob A. Rappaport, Ashley F. Slagle, Eric C. Strain, Ajay D. Wasan, Dennis C. Turk, Robert H. Dworkin	23
18	FDA Approval of Flibanserin — Treating Hypoactive Sexual Desire Disorder 2015 ·New England Journal of Medicine ·Hylton V. Joffe, Christina Y. Chang, Catherine Sewell, (unknown), Christine Nguyen, (unknown), (unknown), (unknown), (unknown), Ashley F. Slagle, Julie Beitz	72
19	The Patient-Reported Outcome (PRO) Consortium: Lessons Learned Along the Path to PRO Instrument Qualification 2014 ·Therapeutic Innovation & Regulatory Science ·Risa P. Hayes, Steven I. Blum, Mark Forrest Gordon, Elisabeth Piault, Laurie B. Burke, Ashley F. Slagle, Stephen Joel Coons	7
20	Policy implications of drug importation 2007 ·Clinical Therapeutics ·Francis B. Palumbo, C. Daniel Mullins, Ashley F. Slagle, (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact